CicaLux is a patented, FDA-registered, eco-friendly wearable device specifically designed to help improve old and prevent new hypertrophic and keloid scar healing following C-sections, hysterectomies, tummy tucks, breast augmentation, and other incisional surgeries. This innovative scar therapy from Europe uses proprietary, non-invasive Triple Action Therapy, which combines the benefits of silicone, infrared heat, and tension-relief tape into one device that can be worn day, night, or both. CicaLux can be used as early as 3 to 6 weeks after surgery—after stitches or staples have been removed and the scar is completely closed and dry. “CicaLux is a unique new scar therapy treatment at the crossroads of aesthetic care and wearable technology,” says Michel Alvarez, CEO, founder, and creator of CicaLux. “It prevents keloids and hypertrophic scars, flattening and minimizing old and new scars to relieve the physical and emotional discomfort that often accompanies scars.”
RELATED STORIES
ASDSA Launches New Patient Safety Database
RealSelf Reveals The Top 20 Highest Rated Cosmetic Procedures Of The Year
Flawless.org Reveals the Most Searched Plastic Surgeries in the U.S.